Zhenghong Liu

Department of Endocrinology, University of Science and Technology of China

Affiliated withUniversity of Science and Technology of China

Research Area

Biography

Zhenghong Liu has not added Biography.
If you are Zhenghong Liu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics\| PubMed ID: 33754074	2021
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. International journal of biological sciences\| PubMed ID: 34131405	2021
The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal transduction and targeted therapy\| PubMed ID: 34253708	2021
Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE mice. Pharmacological research\| PubMed ID: 34954030	2022
A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice. Biochemical and biophysical research communications\| PubMed ID: 35868060	2022
, a coronary artery disease risk gene, mediates endothelial dysfunction. Frontiers in immunology\| PubMed ID: 36091033	2022
Isoginkgetin, a bioactive constituent from Ginkgo Biloba, protects against obesity-induced cardiomyopathy via enhancing Nrf2/ARE signaling. Redox biology\| PubMed ID: 36162256	2022
Growth differentiation factor 15 is dispensable for acetaminophen-induced liver injury in mice. Basic & clinical pharmacology & toxicology\| PubMed ID: 36602134	2023
Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway. Journal of advanced research\| PubMed ID: 38432393	2025
Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E-deficient mice. Acta pharmacologica Sinica\| PubMed ID: 38886550	2024
Endothelial IGFBP6 suppresses vascular inflammation and atherosclerosis. Nature cardiovascular research\| PubMed ID: 39794479	2025
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21. Science advances\| PubMed ID: 40138418	2025
Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake. The Journal of clinical investigation\| PubMed ID: 40166941	2025
A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY. Theranostics\| PubMed ID: 40225566	2025
Revisiting the role of GDF15 in atherosclerosis in mouse and human. Acta pharmacologica Sinica\| PubMed ID: 40307459	2025